Indian Topotecan Exporters: Complete Supplier Ranking with Market Share — 45 Manufacturers (2026) — TransData Nexus

Q: Who is the largest topotecan supplier from India?

INTAS PHARMACEUTICALS LIMITED is the largest topotecan exporter from India with a 87.5% market share and export value of $3.3M.

Q: How many topotecan suppliers are there in India?

There are 45 active topotecan exporters in India, collectively shipping $3.8M worth of topotecan across 558 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top topotecan suppliers from India?

The top 5 topotecan suppliers from India — INTAS PHARMACEUTICALS LIMITED, VENUS REMEDIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, UNITED BIOTECH PRIVATE LIMITED, R.S. SURGIPHARM PRIVATE LIMITED — together control 97.2% of total topotecan export value from India.

Suresh Sormare

Topotecan

India Pharmaceutical Trade Intelligence

$3.8M45 Suppliers51 CountriesHS 30049049

ExportsIndia → POLAND29.8%India → NETHERLANDS15.7%

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: ACCORD HEALTHCARE

Topotecan Suppliers from India (2026) — 45 Exporters, $3.8M Market | TransData Nexus | TransData Nexus

Who Exports Topotecan from India — 45 Suppliers Behind a $3.8M Market

India's topotecan export market is supplied by 45 active exporters who collectively shipped $3.8M across 558 shipments. INTAS PHARMACEUTICALS LIMITED leads with a 87.5% market share, followed by VENUS REMEDIES LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED. The top 5 suppliers together control 97.2% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Topotecan Suppliers & Exporters — 45 manufacturers, $3.8M export market, top destinations and formulations — Topotecan supplier data — 45 exporters · $3.8M market · 558 shipmentsTransData Nexus · Indian Customs Data

Top Topotecan Exporters from India — Ranked by Export Value

INTAS PHARMACEUTICALS LIMITED is the leading topotecan exporter from India, holding a 87.5% share of the $3.8M market across 558 shipments from 45 exporters. The top 5 suppliers — INTAS PHARMACEUTICALS LIMITED, VENUS REMEDIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, UNITED BIOTECH PRIVATE LIMITED, R.S. SURGIPHARM PRIVATE LIMITED — collectively control 97.2% of total export value, indicating a highly concentrated market. Individual shares are: INTAS PHARMACEUTICALS LIMITED (87.5%), VENUS REMEDIES LIMITED (6.0%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (3.0%), UNITED BIOTECH PRIVATE LIMITED (0.5%), R.S. SURGIPHARM PRIVATE LIMITED (0.3%).

Top Topotecan Exporters from India

Ranked by export value · 45 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Topotecan Exporters from India — Ranked by Export Value. 45 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Topotecan exporters

Certification and compliance status for top Topotecan suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Intas Pharmaceuticals Limited	Warning Letter, November	Yes, April 2007	Yes	Not verified	Received FDA warning letter in November 2023; WHO-GMP certified in April 2007.
Sun Pharmaceutical Industries Limited	Approved	Yes, multiple facili	Yes	Not verified	FDA-approved; multiple facilities WHO-GMP certified between 2005 and 2007.

TransData Nexus reviewed the regulatory standing of 2 leading Topotecan exporters from India. 1 hold US FDA facility approvals, 2 maintain WHO-GMP certification, and 2 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Topotecan sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for the production of Active Pharmaceutical Ingredients (APIs). The region's robust infrastructure supports numerous API manufacturers, contributing significantly to India's pharmaceutical exports. While specific data on Topotecan API production in Hyderabad is limited, the city's extensive capabilities in API manufacturing suggest potential involvement in its production.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region hosts major companies like Intas Pharmaceuticals, which, according to TransData Nexus data from 2022 to 2026, accounted for 87.5% of Topotecan exports, valued at $3.3 million. The presence of such industry leaders underscores the region's critical role in the formulation and export of Topotecan.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a significant export gateway for pharmaceutical products. Companies like Sun Pharmaceutical Industries Limited, headquartered in Mumbai, contributed 3.0% to Topotecan exports, amounting to $0.1 million during the 2022-2026 period. The region's strategic location and well-established export infrastructure facilitate the global distribution of pharmaceuticals, including Topotecan.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Topotecan exporters from India

January 2024

M&A

SUN PHARMACEUTICAL INDUSTRIES LIMITED — Sun Pharma acquires remaining stake in Taro Pharmaceuticals

Sun Pharma entered into a definitive merger agreement to acquire all outstanding shares of Taro Pharmaceuticals for $347.73 million. - IMPACT: This acquisition is expected to enhance Sun Pharma's specialty product portfolio, potentially influencing its Topotecan export capabilities.

Impact: This acquisition is expected to enhance Sun Pharma's specialty product portfolio, potentially influencing its Topotecan export capabilities.

TransData Nexus Industry Research · Regulatory filings and press releases · Mar 2026

Common Questions — Topotecan Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which topotecan supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, INTAS PHARMACEUTICALS LIMITED leads with 414 recorded shipments worth $3.3M. VENUS REMEDIES LIMITED (30 shipments) and SUN PHARMACEUTICAL INDUSTRIES LIMITED (4 shipments) are also established high-volume exporters.

Q How many topotecan manufacturers are there in India?

India has 45 active topotecan exporters with a combined export market of $3.8M across 558 shipments to 51 countries. The top 5 suppliers hold 97.2% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for topotecan from India?

Average FOB unit price: $12.87 per unit, ranging from $0.75 to $193.87. Average shipment value: $6.7K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Topotecan

Topotecan

Who Exports Topotecan from India — 45 Suppliers Behind a $3.8M Market

Top Topotecan Exporters from India — Ranked by Export Value

Top Topotecan Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

SUN PHARMACEUTICAL INDUSTRIES LIMITED — Sun Pharma acquires remaining stake in Taro Pharmaceuticals

Common Questions — Topotecan Suppliers from India

Q Which topotecan supplier from India is the most reliable for bulk orders?

Q How many topotecan manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for topotecan from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Analysis Methodology